---

---

symbols : AZN   

save search

---

New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published: 2023-10-13 (Crawled : 13:00) - prnewswire.com
PYXS | $4.58 1.1% 94K |

Professional, Scientific, and T...

| 132.31% | O: 0.0% H: 2.56% C: 2.56%
LLY | News | $741.37 1.37% 800K |

Health Technology

| 20.18% | O: 1.15% H: 0.0% C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K |

Health Technology

| -40.22% | O: -1.63% H: 4.97% C: 2.76%
MRUS | $41.37 2.27% 250K |

Health Technology

| 91.89% | O: 0.47% H: 1.7% C: -0.38%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 2.97% | O: -0.59% H: 0.62% C: -0.56%
fda year review cancer pancreatic

---

Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
Published: 2023-10-12 (Crawled : 12:00) - biospace.com/
FUSN | $21.42 0.47% 780K |

Health Technology

| 482.51% | O: 0.55% H: 3.26% C: 1.09%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.12% | O: 0.6% H: 0.34% C: -0.45%
fpi-2068 presentation pharmaceuticals preclinical therapy

---

AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge
Published: 2023-10-12 (Crawled : 09:00) - biospace.com/
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.12% | O: 0.6% H: 0.34% C: -0.45%
world awards research funding

---

Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio
Published: 2023-10-11 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 8.59% | O: -1.75% H: 0.0% C: 0.0%
AZNCF | News | $138.73 3.7K |

Health Technology

| 3.24% | O: 0.07% H: 0.0% C: -0.38%
NVSEF | News | $95.11 490 |

Health Technology

| -3.27% | O: 0.03% H: 0.0% C: -0.23%
ALPMY | News | $9.53 690K |

Manufacturing

| -30.77% | O: -3.81% H: 5.97% C: 2.57%
VTRS | News A | $11.365 1.02% 1.6M |

Health Technology

| 16.94% | O: 0.0% H: 1.3% C: 0.73%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| -3.76% | O: 1.03% H: 0.03% C: -0.07%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 8.7% | O: 0.72% H: 0.24% C: -0.13%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 12.38% | O: -0.08% H: 0.0% C: 0.0%
SNY | News | $47.85 1.49% 920K |

Health Technology

| -14.69% | O: 1.1% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.12% | O: -0.31% H: 0.34% C: 0.31%
asia growth market

---

Global Influenza Vaccine Market Research Report 2023-2028: Shift in Trends towards mRNA-based Flu Vaccine Gaining Momentum
Published: 2023-10-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 12.78% | O: 0.5% H: 0.0% C: 0.0%
AZNCF | News | $138.73 3.7K |

Health Technology

| 2.84% | O: -0.48% H: 1.63% C: -0.57%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 12.25% | O: 0.94% H: 0.82% C: 0.41%
SNY | News | $47.85 1.49% 920K |

Health Technology

| -14.26% | O: -0.19% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 4.86% | O: 0.24% H: 0.78% C: 0.57%
report vaccine momentum influenza research global trends market

---

Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia
Published: 2023-10-04 (Crawled : 13:00) - globenewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 4.36% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 5.84% | O: 0.42% H: 0.3% C: 0.12%
ARTL | News | $1.3004 15K |

Health Technology

| -5.11% | O: 5.84% H: 0.0% C: -3.45%
cares medical trial

---

Global Sustained Release Excipients Markets, 2017-2022, 2022-2027F, 2032F: Escalating Demand for Advanced Drug Formulations, Fueled by Higher Prevalence of Chronic and Acute Diseases
Published: 2023-09-29 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 11.2% | O: -0.03% H: 0.0% C: -1.26%
AZNCF | News | $138.73 3.7K |

Health Technology

| 1.89% | O: 0.66% H: 0.0% C: -1.46%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| -7.39% | O: 1.18% H: 0.06% C: -1.62%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 11.7% | O: 0.52% H: 0.37% C: -0.77%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 4.02% | O: 2.02% H: 0.0% C: -1.54%
drug global

---

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
Published: 2023-09-22 (Crawled : 09:00) - biospace.com/
AZN | News | $70.87 1.06% 3M |

Health Technology

| 4.64% | O: 2.01% H: 0.2% C: -0.79%
breast her2 cancer trial negative

---

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 1.75% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $150.09 0.65% 3.9M |

Health Technology

| -7.8% | O: 0.52% H: 0.57% C: -0.56%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 6.62% | O: -0.5% H: 0.26% C: -0.69%
LLY | News | $741.37 1.37% 800K |

Health Technology

| 27.46% | O: -1.47% H: 0.0% C: 0.0%
BMY | $49.2 0.12% 2.9M |

Health Technology

| -16.4% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 9.2% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $47.85 1.49% 920K |

Health Technology

| -16.49% | O: -1.16% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.19% | O: 0.19% H: 0.03% C: -1.57%
AMGN | News | $273.38 0.54% 790K |

Health Technology

| 0.17% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

---

Global Bronchial Spasms Treatment Market Set to Reach $505.07 Million by 2031 with a CAGR of 4.1%
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 1.75% | O: -1.13% H: 0.0% C: -0.63%
PFE | News A | $26.24 -0.08% 11M |

Health Technology

| -21.89% | O: -0.45% H: 0.36% C: -1.85%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.19% | O: 0.19% H: 0.03% C: -1.57%
reach treatment global set market

---

Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for 45% of market growth - Technavio
Published: 2023-09-18 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 630 |

Health Technology

| 9.73% | O: 2.7% H: 0.0% C: -5.11%
AZNCF | News | $138.73 3.7K |

Health Technology

| 0.33% | O: -2.01% H: 1.73% C: -2.99%
NVSEF | News | $95.11 490 |

Health Technology

| 11.35% | O: -0.05% H: 0.0% C: -1.31%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| -7.66% | O: 0.06% H: 0.09% C: -0.6%
MDT | $80.95 0.47% 1.7M |

Health Technology

| -1.47% | O: 0.59% H: 1.69% C: 0.67%
GSK | News | $41.13 1.33% 1.1M |

Health Technology

| 8.44% | O: 0.72% H: 0.13% C: -0.93%
BAX | $40.965 1.4% 810K |

Health Technology

| 3.38% | O: -0.13% H: 0.28% C: -0.77%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 9.98% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $47.85 1.49% 920K |

Health Technology

| -15.86% | O: -1.29% H: 0.0% C: 0.0%
BIIB | $194.31 0.1% 470K |

Health Technology

| -23.82% | O: 0.06% H: 0.44% C: -0.64%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 2.72% | O: -0.76% H: 0.16% C: -1.65%
AMGN | News | $273.38 0.54% 790K |

Health Technology

| 4.29% | O: 1.02% H: 0.7% C: -0.09%
america growth market

---

Global Respiratory Syncytial Virus (RSV) Vaccine and Antibody Pipeline Market Forecasts to 2030
Published: 2023-09-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -14.44% | O: 1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.73 3.7K |

Health Technology

| 4.31% | O: 3.97% H: 0.0% C: 0.0%
SNY | News | $47.85 1.49% 920K |

Health Technology

| -15.17% | O: 0.82% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.47% | O: 1.27% H: 0.38% C: -0.54%
antibody vaccine respiratory pipeline global virus market

---

Global Oral Proteins and Peptides Market Valued at $1.57 Billion in 2022, Driven by Rising Demand for Oral Treatments
Published: 2023-09-12 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 4.92% | O: 0.89% H: 0.37% C: -2.49%
NVO | News | $128.31 2.44% 2.2M |

Health Technology

| 27.33% | O: -2.21% H: 1.23% C: 0.11%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 4.14% | O: -0.22% H: 0.33% C: -1.1%
global market

---

Statin Market to grow by USD 2.67 billion from 2022 to 2027, North America to account for 42% of market growth- Technavio
Published: 2023-09-11 (Crawled : 22:00) - prnewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 2.23% | O: -1.86% H: 0.0% C: -0.71%
TMO | News | $574.855 4.83% 1.1M |

Health Technology

| 6.38% | O: -0.27% H: 0.0% C: 0.0%
NVS | News | $97.31 2.3% 2.3M |

Health Technology

| -4.5% | O: 1.45% H: 0.38% C: -0.02%
ABT | News | $108.01 0.88% 1.2M |

Health Technology

| 4.51% | O: -0.08% H: 0.54% C: 0.03%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 5.3% | O: 0.84% H: 0.67% C: 0.27%
AMGN | News | $273.38 0.54% 790K |

Health Technology

| 3.89% | O: 0.37% H: 0.13% C: -0.9%
america market

---

TAGRISSO® (osimertinib) Plus Chemotherapy Extended Median Progression-free Survival by Nearly 9 Months in EGFR-mutated Advanced Lung Cancer in FLAURA2 Phase III Trial
Published: 2023-09-11 (Crawled : 19:00) - biospace.com/
AZN | News | $70.87 1.06% 3M |

Health Technology

| 2.8% | O: -3.31% H: 1.02% C: 0.97%
tagrisso lung cancer trial plus

---

ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial
Published: 2023-09-11 (Crawled : 13:00) - biospace.com/
AZN | News | $70.87 1.06% 3M |

Health Technology

| 2.8% | O: -3.31% H: 1.02% C: 0.97%
enhertu lung cancer tumor trial

---

ENHERTU® Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2 Mutant Advanced Lung Cancer in DESTINY-Lung02 Phase 2 Trial
Published: 2023-09-11 (Crawled : 11:00) - biospace.com/
AZN | News | $70.87 1.06% 3M |

Health Technology

| 2.8% | O: -3.31% H: 1.02% C: 0.97%
enhertu lung her2 cancer tumor trial

---

Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, & Lipoglycopeptide
Published: 2023-09-08 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 3.01% | O: 0.86% H: 0.0% C: -0.1%
IPIX | $0.0042 1.4K |

Manufacturing

| -40.48% | O: 0.0% H: 1.19% C: 0.6%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 12.75% | O: 0.07% H: 0.0% C: 0.0%
CPIX | $1.62 2K |

Health Technology

| -2.99% | O: -2.99% H: 0.0% C: 0.0%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.13% | O: 0.49% H: 0.24% C: -0.16%
global

---

Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market Research
Published: 2023-09-01 (Crawled : 14:30) - prnewswire.com
AZNCF | News | $138.73 3.7K |

Health Technology

| 3.5% | O: 1.46% H: 0.0% C: 0.0%
ALPMY | News | $9.53 690K |

Manufacturing

| -37.05% | O: -0.07% H: 3.3% C: 0.26%
ABBV | News | $170.19 1.37% 1.6M |

Health Technology

| 13.1% | O: -0.35% H: 0.0% C: 0.0%
CPIX | $1.62 2K |

Health Technology

| -1.82% | O: 0.61% H: 0.0% C: 0.0%
BIIB | $194.31 0.1% 470K |

Health Technology

| -27.4% | O: 0.62% H: 0.26% C: -0.68%
AZN | News | $70.87 1.06% 3M |

Health Technology

| 3.41% | O: 0.86% H: 0.16% C: -0.38%
AMGN | News | $273.38 0.54% 790K |

Health Technology

| 6.07% | O: 0.91% H: 0.14% C: -0.76%
research market

---

ENHERTU® Granted Two Breakthrough Therapy Designations in U.S. for Patients Across Multiple HER2 Expressing Cancers
Published: 2023-08-31 (Crawled : 14:30) - biospace.com/
AZN | News | $70.87 1.06% 3M |

Health Technology

| 1.84% | O: 0.19% H: 0.0% C: -1.7%
enhertu her2 granted therapy

---

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.64 166.67% 18M |

AGBA | $2.61 108.8% 41M |

Finance

CZOO | $9.32 86.77% 18M |

EDBL | News | $6.7 78.19% 1.7M |

OPRT | News | $3.37 49.78% 8.9M |

Finance

MTC | $2.14 37.18% 4.9M |

Technology Services

VNRX | $0.8 33.33% 2.9M |

Health Technology

MLEC | $1.79 27.86% 2.6M |

n/a

PALI | $6.29 27.59% 22M |

Manufacturing

MCRB | $0.7902 26.51% 6.9M |

Health Technology

---

Your saved searches

---